Regulation of allergic inflammatory responses by inhibitory receptors

Clinical and Experimental Allergy

Volumn 40, Issue 5, 2010, Pages 700-709

  Shik, D ^a   Munitz, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cytokines; Eosinophils; Immunoreceptor tyrosine based inhibitory motif (ITIM); Inflammation; Inhibitory receptor; Mast cells; Myeloid cells

Indexed keywords

AUTACOID; CD170 ANTIGEN; CD200 ANTIGEN; CD300 ANTIGEN; CD300A ANTIGEN; CD300F ANTIGEN; CD327 ANTIGEN; CD328 ANTIGEN; CD329 ANTIGEN; CD33 ANTIGEN; CELL RECEPTOR; CYTOKINE; IMMUNOGLOBULIN LIKE TRANSCRIPT 2; IMMUNOGLOBULIN LIKE TRANSCRIPT 3; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; IMMUNOGLOBULIN LIKE TRANSCRIPT 5; IMMUNOGLOBULIN RECEPTOR; INHIBITORY RECEPTOR; LECTIN RECEPTOR; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN PRESENTATION; B LYMPHOCYTE; BONE MARROW CELL; CELL ADHESION; CELL FUNCTION; CELL SURVIVAL; CHEMOTAXIS; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EOSINOPHILS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MAST CELLS; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, KIR; SIGNAL TRANSDUCTION;

EID: 77950937947     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03501.x     Document Type: Review

References (86)

1. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 290 : 84 9.
2. Daeron M, Jaeger S, Du Pasquier L, Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 2008 224 : 11 43.
3. Cooper MD. Inhibition of immune cell function. Immunol Rev 2008 224 : 11 43.
4. Lanier LL. NK cell receptors. Annu Rev Immunol 1998 16 : 359 393.
5. Munitz A. Inhibitory receptors on myeloid cells: new targets for therapy? Pharmacol Ther 2010 125 : 128 137.
6. Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S, Reis e Sousa C. Myeloid C-type lectins in innate immunity. Nat Immunol 2006 7 : 1258 1265.
7. Cella M, Dohring C, Samaridis J et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997 185 : 1743 1751.
8. Meyaard L, Adema GJ, Chang C et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997 7 : 283 290.
9. Katz HR. Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors. Immunol Rev 2007 217 : 222 230.
10. Clark GJ, Ju X, Tate C, Hart DN. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 2009 30 : 209 217.
11. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev 2007 7 : 255 266.
12. Kanazawa N, Tashiro K, Miyachi Y. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Immunobiology 2004 209 : 179 190.
13. Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 1997 185 : 795 800.
14. Held W, Cado D, Raulet DH. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med 1996 184 : 2037 2041.
15. Chen CH, Floyd H, Olson NE et al. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 2006 107 : 1459 1467.
16. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev 2009 9 : 465 479.
17. den Dunnen J, Gringhuis SI, Geijtenbeek TB. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother 2009 58 : 1149 1157.
18. Long EO. Regulation of immune responses through inhibitory receptors. Ann Rev Immunol 1999 17 : 875 904.
19. Long EO. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev 2008 224 : 70 84.
20. Fong DC, Malbec O, Arock M, Cambier JC, Fridman WH, Daeron M. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Lett 1996 54 : 83 91.
21. Lu-Kuo JM, Joyal DM, Austen KF, Katz HR. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J Biol Chem 1999 274 : 5791 5796.
22. Katz HR. Inhibitory receptors and allergy. Curr Opin Immunol 2002 14 : 698 704.
23. Lu W, Gong D, Bar-Sagi D, Cole PA. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell 2001 8 : 759 769.
24. Zhang Z, Shen K, Lu W, Cole PA. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J Biol Chem 2003 278 : 4688 4674.
25. Verbrugge A, Rijkers ES, de Ruiter T, Meyaard L. Leukocyte- associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur J Immunol 2006 36 : 190 198.
26. Sayos J, Martinez-Barriocanal A, Kitzig F, Bellon T, Lopez-Botet M. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem Biophys Res Comm 2004 324 : 640 647.
27. Berg KL, Siminovitch KA, Stanley ER. SHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophages. J Biol Chem 1999 274 : 35855 35865.
28. Robson JD, Davidson D, Veillette A. Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3. Mol Cell Biol 2004 24 : 2332 2343.
29. Zhang S, Phillips JH. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J Leukocyte Biol 2006 79 : 363 368.
30. Dietrich J, Nakajima H, Colonna M. Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells. Microbes Infect/Institut Pasteur 2000 2 : 323 329. (Pubitemid 30167667)
31. Kong XN, Yan HX, Chen L et al. LPS-induced down-regulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophages. J Exp Med 2007 204 : 2719 2731.
32. Sinclair NR. Why so many coinhibitory receptors? Scand J Immunol 1999 50 : 10 3.
33. Munitz A, McBride ML, Bernstein JS, Rothenberg ME. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 2008 111 : 5694 5703.
34. Nakayama M, Underhill DM, Petersen TW et al. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J Immunol 2007 178 : 4250 4259.
35. Pereira S, Zhang H, Takai T, Lowell CA. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. J Immunol 2004 173 : 5757 5765.
36. Zhang H, Meng F, Chu CL, Takai T, Lowell CA. The Src family kinases HcK and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 2005 22 : 235 246.
37. Zhou JS, Friend DS, Feldweg AM et al. Prevention of lipopolysaccharide- induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils. J Exp Med 2003 198 : 1243 1251.
38. Brown EJ. Leukocyte migration: dismantling inhibition. Trends Cell Biol 2005 15 : 393 395.
39. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005 155 : 433 440.
40. Ujike A, Takeda K, Nakamura A, Ebihara S, Akiyama K, Takai T. Impaired dendritic cell maturation and increased Th2 responses in PIR-B(-/-) mice. Nat Immunol 2002 3 : 542 548.
41. Kubagawa H, Burrows PD, Cooper MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 1997 94 : 5261 5266.
42. Maeda A, Kurosaki M, Ono M, Takai T, Kurosaki T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med 1998 187 : 1355 1360.
43. Norris HH, Peterson ME, Stebbins CC et al. Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation. J Leukocyt Biol 2007 82 : 1531 1541.
44. Boyce JA, Broide D, Matsumoto K, Bochner BS. Advances in mechanisms of asthma, allergy and immunology in 2008. J Allergy Clin Immunol 2009 123 : 569 574.
45. Munitz A, Levi-Schaffer F. Inhibitory receptors on eosinophil: a direct hit to a possible Achilles heel? J Allergy Clin Immunol 2007 119 : 1382 1387.
46. Karra L, Berent-Maoz B, Ben-Zimra M, Levi-Schaffer F. Are we ready to downregulate mast cells? Curr Opin Immunol 2009 21 : 708 714.
47. Jacobsen EA, Taranova AG, Lee NA, Lee JJ. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007 119 : 1313 1320.
48. Wong MX, Roberts D, Bartley PA, Jackson DE. Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation. J Immunol 2002 168 : 6455 6462.
49. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor Irp60 (CD300a) is expressed and functional on human mast cells. J Immunol 2005 175 : 7989 7995.
50. Castells MC, Klickstein LB, Hassani K et al. gp49B1-alpha9(v)beta3 interaction inhibits antigen-induced mast cell activation. Nat Immunol 2001 2 : 436 442.
51. Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med 2007 204 : 907 920.
52. Yokoi H, Choi OH, Hubbard W et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J Allergy Clin Immunol 2008 121 : 499 505, e1.
53. Katz HR. Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells. Mol Immunol 2002 38 : 1301 1305.
54. Malbec O, Fridman WH, Daeron M. Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB. J Immunol 1999 162 : 4424 4429. (Pubitemid 29314838)
55. Feldweg AM, Friend DS, Zhou JS et al. gp49B1 suppresses stem cell factor-induced mast cell activation secretion and attendant inflammation in vivo. Eur J Immunol 2003 33 : 2262 2268.
56. Bachelet I, Munitz A, Berent-Maoz B, Mankuta D, Levi-Schaffer F. Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. J Immunol 2008 180 : 6064 6069.
57. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008 9 : 1215 1223.
58. Maurer M, Echtenacher B, Hultner L et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998 188 : 2343 2348.
59. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997 390 : 172 175.
60. Kulka M., Alexopoulou L, Flavell RA, Metcalfe DD. Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor 3. J Allergy Clin Immunol 2004 114 : 174 182.
61. Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004 173 : 531 541.
62. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by toll-like receptor 4. J Immunol 2001 167 : 2250 2256.
63. Sun J, Sukhova GK, Wolters PJ et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007 13 : 719 724.
64. Kubo T, Uchida Y, Watanabe Y et al. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J Exp Med 2009 206 : 1971 1982.
65. Floyd H, Ni J, Cornish AL et al. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem 2000 275 : 861 866.
66. Kikly KK, Bochner BS, Freeman SD et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol 2000 105 : 1093 1100.
67. von Gunten S, Vogel M, Schaub A et al. Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies. J Allergy Clin Immunol 2007 119 : 1005 1011.
68. Nutku E, Aizawa A, Hudson SA, Bochner BS. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 2003 101 : 5014 5020.
69. Nutku E, Hudson SA, Bochner BS. Mechanisms of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun 2005 336 : 918 924.
70. Nutku-Bilir E, Hudson SA, Bochner BS. Interkeukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways. Am J Respir Cell Mol Biol 2008 38 : 121 124.
71. Hudson SA, Bovin NV, Schnaar RL, Crocker PR, Bochner BS. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6′-sulfated sialyl Lewis x. J Pharmacol Exp Ther 2009 330 : 608 612.
72. Song DJ, Cho JY, Lee SY et al. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. J Immunol 2009 183 : 5333 5341.
73. Zimmermann N, McBride ML, Yamada Y et al. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy 2008 63 : 1156 1163.
74. von Gunten S, Yousefi S, Seitz M et al. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 2005 106 : 1423 1431.
75. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor Irp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006 107 : 1996 2003.
76. Kumar V, McNerney ME. A new self: MHC-class-I-independent natural killer cell self tolerance. Nat Rev Immunol 2005 5 : 363 374.
77. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 2005 105 : 4722 4729.
78. El-Shazly A, Yamaguchi N, Masuyama K, Suda T, Ishikawa T. Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation. A possible mechanisms for eotaxin-induced human eosinophil chemotaxis. Biochem Biophys Res Commun 1999 264 : 163 170.
79. Fulkerson PC, Zimmermann N, Brandt EB et al. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci USA 2004 101 : 1987 1992.
80. Fulkerson PC, Zhu H, Williams DA, Zimmermann N, Rothenberg ME. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. Blood 2005 106 : 436 443.
81. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 2002 8 : 518 521.
82. Zhu D, Kepley CL, Zhang K, Terada T, Yamada T, Saxon A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 2005 11 : 446 449.
83. Bachelet I, Munitz A, Levi-Schaffer F. Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 2006 117 : 1314 1320.
84. Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 2006 118 : 1082 1089.
85. Tam SW, Demissie S, Thomas D, Daeron M. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 2004 59 : 772 780.
86. Song DJ, Cho JY, Miller M et al. Anti-siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model. Clin Immunol 2009 131 : 157 169.